Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Cisplatin 130 Radiotherapy 94 Carboplatin 85 Paclitaxel 78 Fluorouracil 78 Cyclophosphamide 77 Gemcitabine 72 Capecitabine 66 Docetaxel 65 Doxorubicin 60 Oxaliplatin 59 Etoposide 57 Leucovorin 49 Vincristine 47 Chemotherapy, Adjuvant 42 Cytarabine 38 Dexamethasone 35 Drug Therapy 33 Bevacizumab 30 Epirubicin 29 Neoadjuvant Therapy 28 Pemetrexed 27 Tamoxifen 25 Prednisone 24 Irinotecan 24 Rituximab 21 Methotrexate 21 Radiotherapy, Intensity-Modulated 19 apatinib 18 Vinorelbine 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Eflornithine × Clear all

NCT02796261 2022-01-21

STELLAR

Orbus Therapeutics, Inc.

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡